[Stem cell-targeted therapy--a new strategy for cancer treatment].
Chen
Gang
G
chengang_gulouh@163.com
Xie
Li
L
Liu
Bao-rui
BR
D018528:ATP-Binding Cassette Transporters / Q000378:metabolism; D000241:Adenosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D002454:Cell Differentiation; D054659:Diketopiperazines; D006576:Heterocyclic Compounds, 4 or More Rings; D006801:Humans; D000077341:Lapatinib; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000166:cytology / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011744:Pyrimidinones / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D015398:Signal Transduction; D014227:Triazines / Q000627:therapeutic use; D051153:Wnt Proteins / Q000378:metabolism
C541506:3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester; D018528:ATP-Binding Cassette Transporters; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D054659:Diketopiperazines; D006576:Heterocyclic Compounds, 4 or More Rings; C548732:PKF118-310; D047428:Protein Kinase Inhibitors; D011744:Pyrimidinones; D011799:Quinazolines; D014227:Triazines; D051153:Wnt Proteins; D000077341:Lapatinib; D000241:Adenosine